Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1406 of 6351
-
New vaccine combo aims to rally immune system against tough cancers
Disease control Recruiting nowThis is an open-label, non-randomized, single-center, dose-escalation Phase 1 trial using a heterologous prime-boost strategy of vaccination with Ad5.F35-hGUCY2C-PADRE and recombinant Listeria monocytogenes (Lm-GUCY2C) vaccines in patients with advanced solid tumors including col…
Phase 1 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug combo after transplant aims to stop leukemia relapse and graft-versus-host disease
Disease control Recruiting nowThis phase I trial studies the side effects and best dose of ruxolitinib (Rux) therapy alone (monotherapy) followed by Rux plus azacitidine (AZA) maintenance therapy and to see how well it works in treating patients with acute myeloid leukemia (AML) who are undergoing reduced int…
Phase 1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New hope for aggressive lung cancer: drug combo trial begins
Disease control Recruiting nowThis is a randomized, multicenter, phase Ib study to evaluate the safety and efficacy of ZG006 combined with PD-1/PD-L1 immune checkpoint inhibitors (±chemotherapy) as first-line therapy in Participants with extensive stage small cell lung cancer.
Phase 1 • Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New drug cocktail aims to stop bile duct cancer from coming back
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether adebrelimab combined with S-1 works as an adjuvant treatment for patients with cholangiocarcinoma after curative surgery. It will also learn about the safety of this treatment. The main questions it aims to answer are: * Does a…
Phase 2 • Sponsor: Xingjun Guo • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Brain zaps for Alzheimer's: new study targets gut bugs to boost memory
Disease control Not yet recruitingWhat is this study about? This study focuses on Alzheimer's Disease (AD), a common neurodegenerative disease that affects memory, thinking, and daily life. We aim to explore whether a non-invasive treatment called Repetitive Transcranial Magnetic Stimulation (rTMS) can improve AD…
Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Plasma-Powered gel could speed up healing of chronic wounds
Disease control Recruiting nowThe goal of this randomized controlled trial is to evaluate the efficacy and safety of a novel hydrogel made of Carbopol® 940 functionalized with Plasma-Activated Water (PAW) in patients with chronic wounds (diabetic foot ulcers, pressure injuries, dehiscent wounds, arterial and …
Sponsor: Benjamín Gonzalo Rodríguez Méndez • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for aggressive lymphoma: triple-drug combo enters first human tests
Disease control Not yet recruitingA Single-Arm, Prospective Clinical Study Evaluating the Efficacy and Safety of Sonrotoclax, Zanubrutinib Combined with Obinutuzumab in the First-Line Treatment of Newly Diagnosed Intermediate-to-High-Risk Mantle Cell Lymphoma
Phase 1 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a hospital program stop gun violence before it happens again?
Prevention Recruiting nowThe present study will use an optimization randomized control trial design to test the preliminary efficacy of a Hospital-based Violence Intervention Program (HVIP) in Central Arkansas.
Sponsor: University of Arkansas • Aim: Prevention
Last updated Jun 27, 2026 13:01 UTC
-
New laser microscope could help surgeons save nerves during prostate cancer surgery
Diagnosis Recruiting nowThe goal of this study is to find out whether a new method called "LaserSAFE" can accurately detect cancer at the edge of the prostate (called a positive margin) during prostate surgery. LaserSAFE uses a special microscope in the operating room to quickly scan the prostate after …
Sponsor: University College, London • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC
-
Could a heart drug boost colon cancer treatment?
Disease control Not yet recruitingThe goal of this prospective, single-center, multi-cohort clinical trial is to evaluate the efficacy and safety of neoadjuvant Iparomlimab/Tuvonralimab combined with CAPEOX, with or without propranolol, in patients with locally advanced pMMR (MSS) colon cancer. The main questions…
Phase 2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New drug cocktail targets Hard-to-Treat lung cancer with liver metastases
Disease control Not yet recruitingThe goal of this clinical trial is to learn if the combination therapy with SKB264 and anlotinib works to treat EGFR-TKI-resistant, liver-metastatic non-squamous non-small cell lung cancer (NSCLC). It will also learn about the safety of the combination therapy with SKB264 and anl…
Phase 2 • Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for kids with arthritis: Long-Term drug study launches
Disease control Recruiting nowThis OLE study is designed to evaluate long-term safety, tolerability, and efficacy of filgotinib in patients with polyarticular or systemic juvenile idiopathic arthritis (pJIA-sJIA) who have completed the treatment period/prolonged treatment period of the parent studies and demo…
Phase 3 • Sponsor: Alfasigma S.p.A. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Brain cancer patients get continued access to promising combo therapy in long-term safety study
Disease control Recruiting nowThis clinical trial is a rollover study designed to provide continued access to NBM-BMX and temozolomide (TMZ) for eligible participants with newly diagnosed glioblastoma who have completed the designated treatment in Study NBM-BMX-003 (the parent study), and to evaluate the long…
Phase 1/2 • Sponsor: Novelwise Pharmaceutical Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New migraine pill NB001 put to the test in phase 2 trial
Symptom relief Not yet recruitingThe goal of this observational study is to Evaluate the Efficacy and Safety of NB001 for the Acute Treatment of Migraine in Adult patients diagnosed with migraine.
Phase 2 • Sponsor: Chinese PLA General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
New drug aims to unblock Crohn's-Damaged intestines
Disease control Recruiting nowThis is an open-label, single-arm, phase 4 study to assess the safety and efficacy of mirikizumab in approximately 60 participants with stricturing CD.
Phase 4 • Sponsor: Alimentiv Inc. • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Promising combo aims to shrink tumors in elderly breast cancer patients
Disease control Not yet recruitingEnglish Translation (Professional Medical Version) This study is a multicenter, prospective clinical trial designed to investigate the efficacy and safety of neoadjuvant therapy with trastuzumab plus pertuzumab combined with metronomic vinorelbine chemotherapy in elderly patients…
Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New trial aims to protect Moms' hearts after preeclampsia
Disease control Recruiting nowThe goal of this clinical trial is to learn if a postpartum bundle intervention can improve cardiometabolic health and lifestyle-related factors in women who have had preeclampsia during their first pregnancy. The main questions it aims to answer are: * Does the 9-month interven…
Sponsor: Karolinska Institutet • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Simple vitamins may shield kidneys from chemo damage, new study suggests
Disease control Not yet recruitingCisplatin is a widely used chemotherapy drug for many solid tumors (e.g., lung, bladder, ovarian, head and neck cancers). Despite its efficacy, its clinical use is limited by severe side effects, mainly nephrotoxicity, which occurs in \~30% of patients after treatment. Once insid…
Phase 2/3 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
One shot to ease anxiety? new drug RE104 enters human trial
Symptom relief Recruiting nowThe purpose of this study is to determine if treatment with a single dose of RE104 for Injection reduces anxiety symptoms in participants with Generalized Anxiety Disorder (GAD) as compared to placebo.
Phase 2 • Sponsor: Reunion Neuroscience Inc • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
AI could spot pancreatic cysts more accurately than doctors
Diagnosis Recruiting nowThe aim of this study is to develop and validate an artificial intelligence system named iEUS-PCL (intelligent endoscopic ultrasound system-pancreatic cystic lesions) for detecting and multimodal, multi-class diagnosing pancreatic cystic lesions (PCL) during endoscopic ultrasound…
Sponsor: Qilu Hospital of Shandong University • Aim: Diagnosis
Last updated Sep 05, 2026 00:00 UTC